BLTE
Belite Bio Inc - Adr
3 of the 83 super-investors we track hold BLTE, worth a combined $106M per their latest 13F filings. The largest position: Lee Ainslie at 0.6% of their portfolio. No cohort buying or selling was filed on the name this quarter. Conviction score: 20 of 100 (how strongly the cohort backs it) — ranked #644 of 742 stocks. Conviction rising: 1 more super-investor hold it than in 2026Q1.
Why super-investors own BLTE
BLTE is held by 3 super-investors in our cohort, with a combined position value of $106M. The highest-conviction owner is Lee Ainslie at 0.6% of their portfolio. Cohort ownership has grown from 1 to 3 over the last four quarters — net interest is rising.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2024Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (3) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Lee Ainslie | 0.6% | — 1q | $61M | 396,311 |
| 2 | Joel Greenblatt | <0.1% | 8q | $29M | 186,168 |
| 3 | Stanley Druckenmiller | 0.4% | 2q | $16M | 106,100 |
Owners of BLTE also hold
Long US equity 13F-HR filings only. CUSIP 07782B104. Not investment advice.